A protein helps control immune cell responses to bacteria

The protein CUL4B modulates macrophage responses to Staphylococcus aureus infection.

The protein CUL4B modulates macrophage responses to Staphylococcus aureus infection. This protein acts as a regulator of inflammatory responses during MRSA infection.

Scientists used multi-omics and systems-level analytics to identify CUL4B. They also used CRISPR-mediated deletion of CUL4B in human THP-1 macrophages.

Macrophages (MΦ) play a central role in innate immunity. CUL4B is an E3 ubiquitin ligase. Pyroptosis is a type of cell death. Caspase-1 activation and interleukin-1β production relate to inflammasome signaling.

Deleting CUL4B in human THP-1 macrophages enhanced intracellular bacterial killing. This process reduced cell death, decreased caspase-1 activation, and lowered interleukin-1β production.

In a murine methicillin-resistant Staphylococcus aureus (MRSA) pneumonia model, CUL4B deficiency improved pulmonary bacterial clearance. It also reduced bacteremia and decreased inflammatory tissue injury.

Proteomics showed increased antimicrobial protein abundance and reduced markers of inflammatory damage. These findings suggest a potential host-directed pathway to improve outcomes against this pathogen.

Key facts

  • CUL4B deficiency in a murine MRSA pneumonia model improved pulmonary bacterial clearance.
  • Deleting CUL4B in human THP-1 macrophages reduced cell death and interleukin-1β production.
  • CUL4B is an E3 ubiquitin ligase that modulates macrophage responses to Staphylococcus aureus.

All sections

Edition